Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

被引：6
|
作者：
Niu, Mingshan [1 ,2 ]
Shen, Yangling [1 ]
Qi, Jialei [1 ]
Liu, Xuejiao [3 ]
Sang, Wei [2 ]
Wu, Qingyun [1 ]
Cao, Jiang [2 ]
Chen, Wei [2 ]
Yao, Yao [1 ]
Xu, Kailin [1 ,2 ]
机构：
[1] Xuzhou Med Univ, Blood Dis Inst, Jiangsu Key Lab Bone Marrow Stem Cell, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Insititute Nervous Syst Dis, Xuzhou, Jiangsu, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷 / 11期
基金：
中国国家自然科学基金; 中国博士后科学基金;
关键词：
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; TRIOXIDE; MULTICENTER; THERAPY;
D O I：
10.1007/s00277-017-3093-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1945 / 1948
页数：4
相关论文
共 19 条
  • [1] Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations
    Mingshan Niu
    Yangling Shen
    Jialei Qi
    Xuejiao Liu
    Wei Sang
    Qingyun Wu
    Jiang Cao
    Wei Chen
    Yao Yao
    Kailin Xu
    Annals of Hematology, 2017, 96 : 1945 - 1948
  • [2] PML-RARA mutations confer varying arsenic trioxide resistance
    Bai, Dong-Mei
    Zheng, Xiao-Feng
    PROTEIN & CELL, 2017, 8 (04) : 296 - 301
  • [3] PML-RARA mutations confer varying arsenic trioxide resistance
    DongMei Bai
    XiaoFeng Zheng
    Protein & Cell, 2017, 8 (04) : 296 - 305
  • [4] Light-Induced Degradation Dynamics in Realgar (As4S4)
    Kyono, Atsushi
    Kimata, Mitsuyoshi
    Hatta, Tanao
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2005, 61 : C378 - C378
  • [5] Valence and core-level binding energy shifts in realgar (As4S4) and pararealgar (As4S4) arsenic sulfides
    Bullen, HA
    Dorko, MJ
    Oman, JK
    Garrett, SJ
    SURFACE SCIENCE, 2003, 531 (03) : 319 - 328
  • [6] Anticancer effects of realgar As4S4 particles prepared by nanomilling
    Balaz, P.
    Fabian, M.
    Pastorek, M.
    Cholujova, D.
    Sedlak, J.
    ARSENIC IN GEOSPHERE AND HUMAN DISEASES, 2010, : 350 - 351
  • [7] Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
    Lou, Yinjun
    Ma, Yafang
    Sun, Jianai
    Ye, Xiujin
    Pan, Hanzhang
    Wang, Yungui
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    He, JingSong
    Tong, Hongyan
    Jin, Jie
    ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1829 - 1837
  • [8] CUDC-101 Overcomes Arsenic Trioxide Resistance Via Caspase-Dependent PML-Rara Degradation in Acute Promyelocytic Leukemia
    Zhang, Tianzhuo
    Wang, Jishi
    BLOOD, 2019, 134
  • [9] Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
    Yinjun Lou
    Yafang Ma
    Jianai Sun
    Xiujin Ye
    Hanzhang Pan
    Yungui Wang
    Wenbin Qian
    Haitao Meng
    Wenyuan Mai
    JingSong He
    Hongyan Tong
    Jie Jin
    Annals of Hematology, 2015, 94 : 1829 - 1837
  • [10] Relapse Analysis and Resistance Mutations of PML-Rara Fusion Gene in Acute Promyelocytic Leukemia Patients Treated with All-Trans Retinoic Acid and Arsenic
    Chen, Jiaqi
    Liu, Hongxing
    Wang, Fang
    Chen, Xue
    Zhang, Yang
    Cao, Panxiang
    Ma, Xiaoli
    Li, Yu
    BLOOD, 2021, 138
12